Dear Team,
A nice publication from group of Pharmaceutical industries that discussed challenges in NDSRIs synthesis and how same can be used in risk assessment justification.
It has also thrown light on taking care of quality of NDSRI that to be taken forward for analytical and toxicological testing
https://www.sciencedirect.com/org/science/article/abs/pii/S1083616023001652
